Molecular Partners
MOLN
8 hedge funds and large institutions have $5.99M invested in Molecular Partners in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.01% less ownership
Funds ownership: 2.56% → 2.55% (-0.01%)
3% less capital invested
Capital invested by funds: $6.17M → $5.99M (-$183K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$219K |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$41K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$19.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AlphaCentric Advisors
San Juan,
Puerto Rico
|
-$218K |
| 2 |
Jane Street
New York
|
-$43.8K |
| 3 |
Citigroup
New York
|
-$40K |
MOLN Hedge Fund Activity: Q4 2022 in Review
8 of the 6,236 institutional investors tracked by Wall St. Rank reported a position in Molecular Partners (MOLN) for Q4 2022, worth a combined $5.99M — down 3% from $6.17M a quarter earlier.
Fund positioning in MOLN was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $219K. The largest seller was AlphaCentric Advisors, exiting entirely with an estimated $218K sold.
- 8 institutional investors held Molecular Partners (MOLN) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $5.99M of Molecular Partners stock for Q4 2022, down 3% quarter-over-quarter.
- 2 funds opened new Molecular Partners positions in Q4 2022 and 2 closed out, a net change of 0 holders.
- The largest Molecular Partners buyer in Q4 2022 was Susquehanna International Group, an estimated $219K added.
- The largest Molecular Partners seller in Q4 2022 was AlphaCentric Advisors, an estimated $218K sold.
Based on aggregated 13F filings for Q4 2022.